A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patientsAlberto Zori Comba, A. Schmilovich, Florencia Perazzo et al.|European Journal of Cancer|2001Cited by 37
Paclitaxel in platinum-resistant ovarian cancer patients. Argentine Multicenter Taxol Group.L. Ezcurdia, A.M. Alvarez, S Jovtis et al.|PubMed|1997Cited by 14
Phase II of doxorubicin/taxol in metastatic breast cancerClaudia Pazos, Albertoi Suárez, E. Mickiewicz et al.|Breast Cancer Research and Treatment|1999Cited by 10
Paclitaxel (P) plus carboplatin (C) in advanced non-small cell lung cancer (NSCLC)Eduardo Richardet, Lydia Suarez, Federico Cóppola et al.|Lung Cancer|2000Cited by 0
Uracil/tegafur plus oral calcium folinate in advanced breast cancerEduardo Richardet, Maria Cuevas, Cecilia Pedraza et al.|Academic Production|1999Cited by 0